ArticleMolecular oncology2026

Differential expression of cancer-related genes supports prediction of poor response to first-line treatments in T-ALL pediatric patients with high minimal residual disease.

Antonio Lahera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.